GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)

SHA:600771 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	116.67	258.76	246.4	145.15	393.67
Cash & Short-Term Investments	116.67	258.76	246.4	145.15	393.67
Cash Growth	-54.91%	5.02%	69.76%	-63.13%	65.18%
Accounts Receivable	439.13	666.57	1,033	1,460	1,863
Other Receivables	7.8	173	56.53	143.34	148.7
Receivables	446.93	839.57	1,089	1,603	2,011
Inventory	766.95	569.53	415.04	352.9	362.67
Other Current Assets	36.86	14.36	13.15	24.07	43.73
Total Current Assets	1,367	1,682	1,764	2,125	2,811
Property, Plant & Equipment	663.48	707.24	710.26	738.37	769.75
Long-Term Investments	14.69	25.89	32.89	53.89	54.07
Other Intangible Assets	96.09	93.75	98.54	96.13	100.3
Long-Term Deferred Tax Assets	95.93	91.69	73.69	61.29	36.87
Long-Term Deferred Charges	3.79	4.34	6.16	12.37	9.89
Other Long-Term Assets	34.49	23.28	15.32	15.37	15.71
Total Assets	2,276	2,628	2,701	3,102	3,798
Accounts Payable	72.71	56.41	263.87	489.08	785.34
Accrued Expenses	41.1	508.35	419.04	54.25	57.95
Short-Term Debt	19.95	56.06	165	245.86	299.8
Current Portion of Long-Term Debt	21.99	189.86	62.2	12	10
Current Portion of Leases	-	6.33	1.93	-	-
Current Income Taxes Payable	25.4	0.71	-	1.42	1.37
Current Unearned Revenue	50.83	69.02	38.78	20.25	24.64
Other Current Liabilities	401.72	156.82	106.49	50.62	92.97
Total Current Liabilities	633.7	1,044	1,057	873.49	1,272
Long-Term Debt	-	-	197.6	70	26
Long-Term Leases	33.79	39.11	6.2	-	-
Long-Term Unearned Revenue	15.27	15.1	13.63	15.35	17.82
Long-Term Deferred Tax Liabilities	2.4	13.51	2.7	2.81	2.43
Other Long-Term Liabilities	-	9.27	-	-	10
Total Liabilities	685.17	1,121	1,277	961.65	1,328
Common Stock	489.49	489.49	489.49	492	492
Additional Paid-In Capital	1,588	1,588	1,588	1,637	1,637
Retained Earnings	-504.61	-579.06	-669.14	17.17	333.41
Treasury Stock	-	-	-	-51.22	-51.22
Comprehensive Income & Other	-3.29	-2.52	5.55	4.53	1.01
Total Common Equity	1,570	1,496	1,414	2,099	2,412
Minority Interest	20.9	11.74	9.25	41.42	57.52
Shareholders' Equity	1,591	1,508	1,423	2,141	2,470
Total Liabilities & Equity	2,276	2,628	2,701	3,102	3,798
Total Debt	75.73	291.36	432.93	327.86	335.8
Net Cash (Debt)	40.94	-32.6	-186.54	-182.71	57.87
Net Cash Growth	-	-	-	-	-10.84%
Net Cash Per Share	0.08	-0.07	-0.38	-0.37	0.13
Filing Date Shares Outstanding	464.75	489.49	489.49	489.49	489.49
Total Common Shares Outstanding	464.75	489.49	489.49	489.49	489.49
Working Capital	733.71	638.67	706.65	1,252	1,539
Book Value Per Share	3.38	3.06	2.89	4.29	4.93
Tangible Book Value	1,474	1,402	1,316	2,003	2,312
Tangible Book Value Per Share	3.17	2.86	2.69	4.09	4.72
Buildings	-	728	740.85	744.18	747.38
Machinery	-	161.58	162.29	162.16	157.73
Construction In Progress	-	-	-	-	1.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.